271 related articles for article (PubMed ID: 10945316)
21. Pharmacokinetics of nicotine and cotinine after application of two different nicotine patches under steady state conditions.
Keller-Stanislawski B; Caspary S
Arzneimittelforschung; 1992 Sep; 42(9):1160-2. PubMed ID: 1445487
[TBL] [Abstract][Full Text] [Related]
22. Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy.
Lawson GM; Hurt RD; Dale LC; Offord KP; Croghan IT; Schroeder DR; Jiang NS
J Clin Pharmacol; 1998 Jun; 38(6):502-9. PubMed ID: 9650539
[TBL] [Abstract][Full Text] [Related]
23. Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats.
Rezvani AH; Bushnell PJ; Levin ED
Psychopharmacology (Berl); 2002 Dec; 164(4):369-75. PubMed ID: 12457266
[TBL] [Abstract][Full Text] [Related]
24. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
[TBL] [Abstract][Full Text] [Related]
25. Precessation treatment with nicotine skin patch facilitates smoking cessation.
Rose JE; Behm FM; Westman EC; Kukovich P
Nicotine Tob Res; 2006 Feb; 8(1):89-101. PubMed ID: 16497603
[TBL] [Abstract][Full Text] [Related]
26. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
[TBL] [Abstract][Full Text] [Related]
27. Exposure to high ambient temperature increases absorption and plasma concentrations of transdermal nicotine.
Vanakoski J; Seppälä T; Sievi E; Lunell E
Clin Pharmacol Ther; 1996 Sep; 60(3):308-15. PubMed ID: 8841153
[TBL] [Abstract][Full Text] [Related]
28. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
Cárdenas L; Busto UE; MacDonald A; Corrigall WA
Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
[TBL] [Abstract][Full Text] [Related]
29. Mecamylamine attenuates the subjective stimulant-like effects of alcohol in social drinkers.
Chi H; de Wit H
Alcohol Clin Exp Res; 2003 May; 27(5):780-6. PubMed ID: 12766622
[TBL] [Abstract][Full Text] [Related]
30. Nicotine intake and dose response when smoking reduced-nicotine content cigarettes.
Benowitz NL; Jacob P; Herrera B
Clin Pharmacol Ther; 2006 Dec; 80(6):703-14. PubMed ID: 17178270
[TBL] [Abstract][Full Text] [Related]
31. Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers.
Feng S; Kapur S; Sarkar M; Muhammad R; Mendes P; Newland K; Roethig HJ
Toxicol Lett; 2007 Sep; 173(2):101-6. PubMed ID: 17716838
[TBL] [Abstract][Full Text] [Related]
32. Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment.
Gourlay SG; Benowitz NL; Forbes A; McNeil JJ
Eur J Clin Pharmacol; 1997; 51(5):407-14. PubMed ID: 9049583
[TBL] [Abstract][Full Text] [Related]
33. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
Rose JE; Behm FM; Ramsey C; Ritchie JC
Nicotine Tob Res; 2001 Nov; 3(4):383-90. PubMed ID: 11694206
[TBL] [Abstract][Full Text] [Related]
34. Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine.
Hukkanen J; Gourlay SG; Kenkare S; Benowitz NL
Clin Pharmacol Ther; 2005 Mar; 77(3):159-69. PubMed ID: 15735610
[TBL] [Abstract][Full Text] [Related]
35. Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans.
Jacob P; Yu L; Wilson M; Benowitz NL
Biol Mass Spectrom; 1991 May; 20(5):247-52. PubMed ID: 1883864
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous determination of mecamylamine, nicotine, and cotinine in plasma by gas chromatography-mass spectrometry.
Jacob P; Wu S; Yu L; Benowitz NL
J Pharm Biomed Anal; 2000 Sep; 23(4):653-61. PubMed ID: 10975241
[TBL] [Abstract][Full Text] [Related]
37. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB
Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587
[TBL] [Abstract][Full Text] [Related]
38. Effects of combined systemic alcohol and central nicotine administration into ventral tegmental area on dopamine release in the nucleus accumbens.
Tizabi Y; Copeland RL; Louis VA; Taylor RE
Alcohol Clin Exp Res; 2002 Mar; 26(3):394-9. PubMed ID: 11923594
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
[TBL] [Abstract][Full Text] [Related]
40. Nicotine dose-concentration relationship and pregnancy outcomes in rat: biologic plausibility and implications for future research.
Hussein J; Farkas S; MacKinnon Y; Ariano RE; Sitar DS; Hasan SU
Toxicol Appl Pharmacol; 2007 Jan; 218(1):1-10. PubMed ID: 17141291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
